BIM, PUMA, and the Achilles’ Heel of Oncogene Addiction

Sci. Signal.  26 Mar 2013:
Vol. 6, Issue 268, pp. pe12
DOI: 10.1126/scisignal.2004113

You are currently viewing the abstract.

View Full Text
As a service to the community, AAAS/Science has made this article free with registration.


Cancer cells undergo extensive genetic and epigenetic rewiring to support the malignant phenotype, and yet cell survival and proliferation often remain dependent on one or a limited number of driver mutations. This is the concept of oncogene addiction, the elucidation of which has led to substantial progress in therapeutic interventions. However, because resistance mechanisms often emerge, explicating the pathways that connect therapeutic oncogene inactivation to the cell death machinery is critical to exploiting additional synthetic lethal opportunities.

View Full Text